Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?

PP Glasziou^*, SD Eckermann, SE Mulray, RJ Simes, AJ Martin, AC Kirby, JP Hall, S Caleo, HD White, AM Tonkin

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review